Professor Mark Hutchinson
Director, Centre for Nanoscale BioPhotonics, The University of Adelaide,
Professor Hutchinson is the Director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), a Professor within the Adelaide Medical School, and an ARC Future Fellow at the University of Adelaide.
Professor Hutchinson returned to the University of Adelaide in 2009 as an NHMRC CJ Martin Research Fellow, and established the Neuroimmunopharmacology research laboratory. From 2005 to 2009 Mark worked in the world leading laboratory of Prof Linda Watkins in the Center for Neuroscience at the University of Colorado at Boulder. Here he pioneered with Prof Watkins the research which has led to the discovery of novel drug activity at innate immune receptors.
Mark’s research has implicated the brain immune-like cells in the action of drugs of dependence and the negative side effects of pain treatments. His work has enabled the translation of compounds at the lab bench to clinical agents used at the bedside. Mark has published over 160 papers in journals and refereed conference proceedings.
He is now added Director of the CNBP to his roles. The CNBP is an ARC Centre of Excellence with $47M of funding committed for 7 years, headquartered at The University of Adelaide, with nodes at Macquarie University, Sydney and the RMIT, Melbourne. We are partnered with universities and companies in Europe, the US and China, as well as other Australian institutions.
The CNBP has a mission to "Discover new approaches to measure nano-scale dynamic phenomena in living systems”.